HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration.

Abstract
Common variable immunodeficiency is the most common symptomatic primary immunodeficiency in adulthood. Pregnant women with common variable immunodeficiency have different needs from other patients with the same disease. Because of immature state of the fetal and neonatal immune system, transplacental transfer of immunoglobulin G (IgG) has a relevant role in protecting the infant. We here report on a high-risk pregnant woman with common variable immunodeficiency with adverse reactions to intravenous immunoglobulin that was successfully rescued with a new Ig human intravenous, 10% liquid preparation. The treatment was tailored to the health status and characteristics of the patient. The new product was safe and well tolerated. The mother did not report any infections during pregnancy and the baby had a healthy course with 'protective' serum IgG levels. Our case is a further demonstration that intravenous immunoglobulin tolerability in patients with immunodeficiency could be linked to a product's characteristics.
AuthorsMaria Giovanna Danieli, Romina Moretti, Lucia Pettinari, Simona Gambini
JournalBMJ case reports (BMJ Case Rep) Vol. 2012 (Dec 17 2012) ISSN: 1757-790X [Electronic] England
PMID23257273 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunoglobulins, Intravenous
  • Immunologic Factors
Topics
  • Adult
  • Common Variable Immunodeficiency (drug therapy)
  • Female
  • Humans
  • Immunoglobulins, Intravenous (adverse effects, therapeutic use)
  • Immunologic Factors (therapeutic use)
  • Pregnancy
  • Pregnancy Complications (drug therapy, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: